Marshall Wace, LLP Spring Works Therapeutics, Inc. Transaction History

Marshall Wace, LLP

$81.7 Billion
Q2 2025

A detailed history of Marshall Wace, LLP transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 185,540 shares of SWTX stock, worth $8.72 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

185,540

Previous 50,938 264.25%

Holding current value

$8.72 Million

Previous $2.25 Million 287.98%

% of portfolio

0.01%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$34.43 - $46.99 $4.63 Million - $6.32 Million	134,602 Added 264.25%	185,540 $8.72 Million
Q1 2025 May 15, 2025	BUY	$32.5 - $59.93 $1.66 Million - $3.05 Million	50,938 New	50,938 $2.25 Million
Q3 2024 Nov 14, 2024	SELL	$32.04 - $42.76 $11.9 Million - $15.9 Million	-371,287 Reduced 15.91%	1,961,830 $62.9 Million
Q2 2024 Aug 14, 2024	SELL	$36.06 - $47.62 $22.8 Million - $30.2 Million	-633,505 Reduced 21.35%	2,333,117 $87.9 Million
Q1 2024 May 15, 2024	SELL	$36.5 - $52.5 $2.13 Million - $3.06 Million	-58,237 Reduced 1.93%	2,966,622 $146 Million
Q4 2023 Feb 14, 2024	BUY	$18.94 - $37.24 $32.9 Million - $64.7 Million	1,736,606 Added 134.8%	3,024,859 $110 Million
Q3 2023 Nov 14, 2023	BUY	$23.12 - $31.38 $1.86 Million - $2.53 Million	80,613 Added 6.68%	1,288,253 $29.8 Million
Q2 2023 Aug 14, 2023	BUY	$23.15 - $32.71 $23.7 Million - $33.5 Million	1,023,306 Added 555.14%	1,207,640 $31.7 Million
Q1 2023 May 15, 2023	BUY	$24.97 - $34.05 $4.6 Million - $6.28 Million	184,334 New	184,334 $4.74 Million
Q2 2022 Aug 15, 2022	SELL	$18.36 - $60.07 $12.9 Million - $42.3 Million	-704,597 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$48.97 - $65.46 $14.5 Million - $19.4 Million	297,078 Added 72.9%	704,597 $39.8 Million
Q4 2021 Feb 14, 2022	BUY	$53.3 - $75.84 $20.6 Million - $29.3 Million	386,626 Added 1850.5%	407,519 $25.3 Million
Q3 2021 Nov 15, 2021	BUY	$62.66 - $88.26 $1.31 Million - $1.84 Million	20,893 New	20,893 $1.33 Million
Q2 2021 Aug 13, 2021	SELL	$67.45 - $85.63 $4.39 Million - $5.57 Million	-65,044 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$65.1 - $93.59 $4.23 Million - $6.09 Million	65,044 New	65,044 $4.79 Million

Others Institutions Holding SWTX

# of Institutions

271

Shares Held

72M

Call Options Held

11.8M

Put Options Held

1.27M

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.93B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Spring Works Therapeutics, Inc. Transaction History